Palvella Therapeutics, Inc. (PVLA) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $389.85M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $89.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $383.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $95.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $12.00K; Additional Paid in CapitalUSD $163.34M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $83.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $161.30M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $104.00K.
Palvella Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital, Preferred Stock USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Partners' Capital Account, Units, Sold in Private Placement shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $14.00K | $389.85M | $89.00K | $-173.09M | $216.87M | 3 month · $5.00K | 3 month · $5.16M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $14.00K | $383.42M | $95.00K | $-151.22M | $232.31M | (m) | 3 month · $3.38M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $12.00K | $163.34M | $83.00K | $-135.45M | $27.98M | 12 month · $154.00K | 12 month · $6.40M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $11.00K | $161.30M | $104.00K | $-122.74M | $38.68M | (m) | 3 month · $1.79M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $11.00K | $159.27M | $-111.00K | $-111.39M | $47.78M | (m) | 3 month · $1.43M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $11.00K | $157.49M | $-3.00K | $-101.92M | $55.58M | (m) | 3 month · $1.09M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $11.00K | $156.33M | $3.00K | $-93.73M | $62.61M | (m) | 12 month · $830.00K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $1.00K | $342.92M | $-316.00K | $-326.33M | $-87.40M | (m) | 3 month · $199.00K 9 month · $1.22M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $1.00K | $342.59M | $-436.00K | $-323.45M | $-80.83M | (m) | 3 month · $217.00K 6 month · $893.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00K | $342.17M | $-346.00K | $-319.86M | $-76.87M | (m) | 3 month · $146.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $0.00 | $1.82M | $0.00 | $-76.30M | $-74.48M | 12 month · $700.00K | 12 month · $603.00K | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $99.00K | $341.13M | $-339.00K | $-310.38M | $30.51M | (m) | 3 month · $966.00K 9 month · $2.90M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $99.00K | $340.16M | $-137.00K | $-299.63M | $40.50M | (m) | 3 month · $1.05M 6 month · $1.93M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $74.00K | $319.41M | $-426.00K | $-303.60M | $15.46M | (m) | 3 month · $884.00K | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $74.00K | $318.53M | $-254.00K | $-290.42M | $-93.78M | 12 month · $300.00K | 12 month · $4.40M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $74.00K | $317.49M | $524.00K | $-282.32M | $35.77M | (m) | 3 month · $974.00K 9 month · $3.45M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $74.00K | (m) | $625.00K | $-272.58M | $44.37M | (m) | 3 month · $1.30M 6 month · $2.48M | $316.25M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $74.00K | (m) | $953.00K | $-262.25M | $53.45M | (m) | 3 month · $1.18M | $314.67M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $72.00K | $307.00M | $829.00K | $-257.14M | $50.76M | (m) | 12 month · $5.21M | $307.00M | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $72.00K | (m) | $616.00K | $-247.61M | $53.85M | 3 month · $800.00K | 3 month · $1.37M 9 month · $3.90M | $302.59M | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $67.00K | (m) | $234.00K | $-231.08M | $46.72M | (m) | 3 month · $1.33M 6 month · $2.52M | $277.50M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $60.00K | (m) | $194.00K | $-215.58M | $38.24M | (m) | 3 month · $1.20M | $253.56M | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $56.00K | (m) | $-295.00K | $-211.41M | $31.03M | (m) | 12 month · $5.09M | $242.67M | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $56.00K | (m) | $-782.00K | $-197.01M | $43.69M | (m) | 3 month · $1.40M 9 month · $3.92M | $241.42M | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $52.00K | (m) | $-1.06M | $-182.72M | $46.67M | (m) | 3 month · $1.24M 6 month · $2.52M | $230.41M | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $55.00K | (m) | $-1.23M | $-177.77M | $49.81M | (m) | 3 month · $1.28M | $228.75M | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $55.00K | (m) | $-2.00M | $-174.18M | $51.35M | (m) | 12 month · $5.37M | $227.47M | (m) | (m) | (m) |
| 2019-09-30 | (m) | $49.00K | (m) | $-697.00K | $-173.41M | $20.64M | (m) | 3 month · $1.52M 9 month · $4.26M | $194.69M | (m) | (m) | (m) |
| 2019-06-30 | (m) | $49.00K | (m) | $-2.71M | $-170.81M | $19.48M | (m) | 3 month · $1.45M 6 month · $2.74M | $192.96M | (m) | (m) | (m) |
| 2019-03-31 | (m) | $49.00K | (m) | $-2.06M | $-159.06M | $30.16M | (m) | 3 month · $1.29M | $191.22M | (m) | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | (m) | $-148.71M | $38.29M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $54.00K | (m) | $-2.98M | $-147.07M | $39.94M | (m) | 12 month · $4.94M | $189.93M | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $54.00K | (m) | $-3.05M | $-135.38M | $50.26M | 3 month · $3.37M 9 month · $3.37M | 3 month · $1.30M 9 month · $3.67M | $188.64M | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $54.00K | (m) | $-2.57M | $-129.23M | $55.31M | 3 month · $3.37M 6 month · $3.37M | 3 month · $1.36M 6 month · $2.36M | $187.07M | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $54.00K | (m) | $-5.97M | $-129.03M | $50.69M | 3 month · $3.37M | 3 month · $1.00M | $185.64M | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $45.00K | (m) | $-4.70M | $-120.31M | $11.52M | (m) | 12 month · $3.05M | $136.48M | (m) | (m) | (m) |
| 2017-09-30 | $5.00 | $44.70K | (m) | $-2.49M | $-127.80M | $4.56M | (m) | (m) | $134.80M | (m) | (m) | (m) |
| 2017-06-30 | $5.00 | $43.84K | (m) | $-2.09M | $-120.74M | $9.33M | (m) | (m) | $132.13M | (m) | (m) | (m) |
| 2017-03-31 | $5.00 | $43.06K | (m) | $-1.45M | $-110.66M | $18.04M | (m) | (m) | $130.10M | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $43.00K | (m) | $-1.50M | $-102.67M | $25.23M | (m) | 12 month · $1.91M | $129.35M | (m) | (m) | (m) |
| 2016-09-30 | $5.00 | $43.06K | (m) | $-1.33M | $-96.11M | $31.48M | (m) | (m) | $128.87M | (m) | (m) | (m) |
| 2016-06-30 | $5.00 | $43.06K | (m) | $-1.33M | $-89.91M | $37.29M | (m) | (m) | $128.48M | (m) | (m) | 1 month · 8.19M |
| 2016-03-31 | (m) | $39.83K | (m) | $-1.43M | $-84.03M | $27.18M | (m) | (m) | $112.60M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $39.83K | $112.23M | $-1.27M | $-79.87M | $31.13M | (m) | 12 month · $1.16M | $112.23M | (m) | (m) | (m) |
| 2015-09-30 | (m) | $39.76K | $111.73M | $-1.15M | $-76.96M | $33.65M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $29.43K | $85.50M | $-1.34M | $-73.04M | $11.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $29.43K | $85.16M | $-1.45M | $-69.51M | $14.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $29.28K | $84.63M | $-843.10K | $-65.81M | $18.01M | (m) | 12 month · $571.38K | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $6.25K | (m) | (m) | $-29.90K | (m) | (m) | (m) | (m) | $22.75K | $-904.00 | (m) |
| 2014-06-30 | (m) | $6.10K | $19.90K | (m) | $-15.99K | $10.01K | (m) | (m) | (m) | $19.90K | $10.01K | (m) |
| 2014-03-31 | (m) | $5.00K | (m) | (m) | $-9.78K | (m) | (m) | (m) | (m) | $0.00 | $-4.78K | (m) |
| 2013-12-31 | (m) | $11.83K | $57.61M | $-956.27K | $-55.96M | $585.01K | (m) | (m) | (m) | (m) | $-3.23K | (m) |
| 2013-06-30 | (m) | $5.00K | (m) | (m) | $-274.00 | (m) | (m) | (m) | (m) | $0.00 | $4.73K | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | $495.70K | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |